December 3, 2020

Volume X, Number 338

Advertisement

December 03, 2020

Subscribe to Latest Legal News and Analysis

December 02, 2020

Subscribe to Latest Legal News and Analysis

December 01, 2020

Subscribe to Latest Legal News and Analysis

November 30, 2020

Subscribe to Latest Legal News and Analysis

Private Equity Purchasers and SPACs May Be "Preferred" Divestiture Buyers under New DOJ Guidelines for Merger Remedies

What happened?

On September 3, 2020, the Department of Justice (“DOJ”) issued a revised Merger Remedies Manual, which sets forth the Division’s framework for implementing remedies to resolve antitrust concerns in merger cases. The Manual specifically calls out Private Equity firms as potentially preferred buyers in certain situations. We believe the policy behind that announcement applies equally to Special Purpose Acquisition Companies (“SPACs”). For a general description of the revised rules, please see our memo, Justice Department Revises Merger Remedies Guidelines.

Why does this matter?

When DOJ or the Federal Trade Commission (“FTC”) identifies antitrust concerns with proposed transactions, they usually will seek the divestiture of a standalone business. In evaluating a proposed remedy, the Merger Remedies Manual states that the Division “will use the same criteria to evaluate both strategic purchasers and purchasers that are funded by private equity or other investment firms.” Significantly, the new Manual now explicitly recognizes that “in some cases a private equity purchaser may be preferred.” Citing the FTC’s 2017 Merger Remedies Report, DOJ noted that “in some cases funding from private equity and other investment firms was important to the success of the remedy because the purchaser had flexibility in investment strategy, was committed to the divestiture, and was willing to invest more when necessary.” This conclusion would equally support SPACs as divestiture buyer candidates. DOJ noted further that the FTC’s study also identified cases of failed divestitures where the divestiture buyer’s lack of flexibility in financing “contributed significantly.” Aside from investment commitment and flexibility, private-equity-backed purchasers and SPACs are even more attractive as divestiture buyers where the acquirer’s existing portfolio companies pose no competitive concerns.

The Merger Remedies Manual sets forth three fundamental tests for the approval of a proposed purchaser:

  1. Divestiture of the assets to the proposed purchaser must not itself cause competitive harm.

  2. The Division “must be certain” that the purchaser has the incentive to use the divestiture assets to compete in the market.

  3. The Division will evaluate the “fitness” of the proposed purchaser to ensure that the purchaser “has sufficient acumen, experience, and financial capability to compete effectively in the market over the long term.”

Private equity firms and SPACs seeking to purchase businesses should be prepared to show that they will be viable and strong competitors in terms of financial resources, management expertise, strategic vision, and incentive to compete and grow the target businesses over the long term.

© Copyright 2020 Cadwalader, Wickersham & Taft LLPNational Law Review, Volume X, Number 252
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement
Advertisement

About this Author

Joel Mitnick, Cadwalader Law Firm, New York, Finance and Litigation Law Attorney
Partner

Joel Mitnick is a partner in the Antitrust and Global Litigation groups. Joel’s practice focuses on antitrust matters on behalf of a wide array of financial market, life science, media, service industry and industrial clients. Joel represents clients in Federal and State antitrust investigations, antitrust class actions and merger clearance proceedings. He has tried merger cases to verdict and briefed antitrust class actions up to the United States Supreme Court. Joel also counsels some of the nation’s most prominent activist and passive hedge funds and private equity...

212-504-6555
Ngoc Pham Hulbig, Cadwalader, coordinated competition filing attorney, high stakes transactions lawyer
Counsel

Ngoc Pham Hulbig's practice focuses on counseling regarding U.S. and global premerger notification requirements. She has extensive experience in preparing filings under the Hart-Scott-Rodino Act and has coordinated competition filings around the world for complex and high-stakes transactions. She also counsels clients in the full range of antitrust matters, including mergers and acquisitions, joint ventures, and in connection with investigations by the U.S. Department of Justice and the U.S. Federal Trade Commission. Ngoc has experience representing clients in matters...

704-348-5282
Advertisement
Advertisement